Na Li - McMaster Experts

Affiliations

Faculty of Engineering, McMaster University
Member, McMaster Centre for Transfusion Research (MCTR), Faculty of Health Sciences
Adjunct Assistant Professor, Computing and Software, Faculty of Engineering

Scholarly Activity in McMaster Experts

Co-author Network

Scholarly Activity
Research
Contact
View All

selected scholarly activity

chapters
- A Primer on Biostatistics. 590-608. 2022
conferences
- Enhancing Large Language Models with Human Expertise for Disease Detection in Electronic Health Records. Proceedings - 2024 IEEE International Conference on Digital Health, ICDH 2024. 129-131. 2024
- Equitable Allocation of Scarce Resources During the Covid-19 Pandemic: A Case Study for Convalescent Plasma Distribution. Proceedings - Winter Simulation Conference. 982-993. 2023
- An evaluation of the clinical impacts of 7‐day platelets. Transfusion. 480-493. 2023
- Transfusion Reactions Following the Implementation of Seven Day Platelets. Transfusion. 256A-256A. 2020
- Perioperative Eltrombopag or Intravenous Immune Globulin for Patients with Immune Thrombocytopenia: A Multicenter Randomized Trial. Blood. 896-896. 2019
- Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study. Blood. 710-710. 2019
- Sex‐mismatched red blood cell transfusions and mortality: A systematic review and meta‐analysis. Vox Sanguinis. 505-516. 2019
- Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study: A Perioperative Management Plan for Patients with Atrial Fibrillation Who Are Receiving a Direct Oral Anticoagulant. Blood. 2018
- Urgent Management of Bleeding in Immune Thrombocytopenia: Towards a Standardized Protocol in the Emergency Department. Blood. 3517-3517. 2018
- Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia. Blood. 234-241. 2018
journal articles
- Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancer. Journal of Thrombosis and Haemostasis. 22:727-737. 2024
- Demand forecasting for platelet usage: From univariate time series to multivariable models. PLoS ONE. 19:e0297391-e0297391. 2024
- Deep learning for platelet transfusion. Blood. 142:2231-2232. 2023
- An unsupervised learning approach to identify immunoglobulin utilization patterns using electronic health records. Transfusion. 63:2234-2247. 2023
- Data-driven fair resource allocation for novel emerging epidemics: a COVID-19 Convalescent Plasma case study. INFOR: Information Systems and Operational Research. 61:559-588. 2023
- Blood Demand Forecasting and Supply Management: An Analytical Assessment of Key Studies Utilizing Novel Computational Techniques. Transfusion Medicine Reviews. 37:150768-150768. 2023
- P‐TS‐10 | An Unsupervised Learning Approach to Identify Immunoglobulin Utilization Patterns Using Electronic Health Records. Transfusion. 63:261A-262A. 2023
- Immunoglobulin utilization in Canada: a comparative analysis of provincial guidelines and a scoping review of the literature. Allergy, Asthma and Clinical Immunology. 19:85. 2023
- Lung ultrasound: A comparison of image interpretation accuracy between curvilinear and phased array transducers. Australasian Journal of Ultrasound in Medicine. 26:150-156. 2023
- Do Children With an Allergic Transfusion Reaction Require Premedication For All Blood Products?. Journal of Pediatric Hematology/Oncology. 45:e578-e581. 2023
- KEL1 negative red cell transfusions for females of current or future child‐bearing potential: A clinical impact and feasibility study. Transfusion. 63:59-68. 2023
- Rituximab Toxicity after Preemptive or Therapeutic Administration for Post-Transplant Lymphoproliferative Disorder. Transplantation and Cellular Therapy. 29:43.e1-43.e8. 2023
- “Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia”: reply. Journal of Thrombosis and Haemostasis. 21:185-185. 2023
- A data‐informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma. Transfusion. 62:2525-2538. 2022
- Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure. Journal of Thrombosis and Haemostasis. 20:2953-2963. 2022
- Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 20:2988-2997. 2022
- Hospital red blood cell and platelet supply and utilization from March to December of the first year of the COVID‐19 pandemic: The BEST collaborative study. Transfusion. 62:1559-1570. 2022
- Database‐driven research and big data analytic approaches in transfusion medicine. Transfusion. 62:1427-1434. 2022
- Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. Blood Advances. 6:785-792. 2022
- Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Nature Medicine. 28:212-212. 2022
- From demand forecasting to inventory ordering decisions for red blood cells through integrating machine learning, statistical modeling, and inventory optimization. Transfusion. 62:87-99. 2022
- Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19. Nature Medicine. 28:53-58. 2022
- Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Nature Medicine. 27:2012-2024. 2021
- Necrotizing enterocolitis and mortality after transfusion of ABO non‐identical blood. Transfusion. 61:3094-3103. 2021
- Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia. Blood Advances. 5:4256-4264. 2021
- Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria. British Journal of Haematology. 194:439-443. 2021
- From Pathways to Practice: Impact of Implementing Mobilization Recommendations in Head and Neck Cancer Surgery with Free Flap Reconstruction. Cancers. 13:2890-2890. 2021
- Impact of Early Mobilization on Recovery after Major Head and Neck Surgery with Free Flap Reconstruction. Cancers. 13:2852-2852. 2021
- A decision integration strategy for short-term demand forecasting and ordering for red blood cell components. Operations Research for Health Care. 29:100290-100290. 2021
- Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial. Trials. 22:323. 2021
- A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulant. Research and Practice in Thrombosis and Haemostasis. 5:159-167. 2021
- Cluster‐randomized trials in transfusion medicine. Transfusion. 60:2470-2473. 2020
- Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study. Journal of the American Heart Association. 9:e017316. 2020
- Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. The Lancet Haematology. 7:e640-e648. 2020
- Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure. Blood Advances. 4:3520-3527. 2020
- Effect of Direct Oral Anticoagulant, Patient, and Surgery Characteristics on Clinical Outcomes in the Perioperative Anticoagulation Use for Surgery Evaluation Study. TH Open. 04:e255-e262. 2020
- Management of major bleeds in patients with immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 18:1783-1790. 2020
- Combination of two complementary automated rapid assays for diagnosis of heparin‐induced thrombocytopenia (HIT). Journal of Thrombosis and Haemostasis. 18:1435-1446. 2020
- Not all red cell concentrate units are equivalent: international survey of processing and in vitro quality data. Vox Sanguinis. 114:783-794. 2019
- Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Internal Medicine. 179:1469-1469. 2019
- Neutrophil and Monocyte Counts in Heparin-Induced Thrombocytopenia. Thrombosis and Haemostasis. 119:941-951. 2019
- Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale. Thrombosis and Haemostasis. 119:500-507. 2019
- Optimising key performance indicator adherence with application to emergency department congestion. European Journal of Operational Research. 272:313-323. 2019
- Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin. Transfusion. 58:2729-2735. 2018
- Erratum to: The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and Rationale. Thrombosis and Haemostasis. 118:1679-1680. 2018
- Nonlinear Accumulating Priority Queues with Equivalent Linear Proxies. Operations Research. 65:1712-1721. 2017
- Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry. Blood Advances. 1:2414-2420. 2017
- The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia. Research and Practice in Thrombosis and Haemostasis. 1:103-111. 2017
- The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale. Thrombosis and Haemostasis. 117:2415-2424. 2017
- Multi-server accumulating priority queues with heterogeneous servers. European Journal of Operational Research. 252:866-878. 2016
- Involvement of Caveolin-1 in CD83 Internalization in Mouse Dendritic Cells. Cell Transplantation. 24:1395-1404. 2015
- Erratum. Stem Cells. 31:1030-1030. 2013
- Endothelial Nitric Oxide Synthase Promotes Bone Marrow Stromal Cell Migration to the Ischemic Myocardium via Upregulation of Stromal Cell-Derived Factor-1α . Stem Cells. 27:961-970. 2009
preprints